4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000018
Chief Medical Officer sold 417 shares at $25.65 ($10,696)
- Chief Medical Officer acquired 417 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-03-17 | Option exercise 10b5-1 | +417 | $15.44 | $6,438 | 76,557 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-17 | Sale 10b5-1 | −417 | $25.65 | $10,696 | 76,140 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-03-17 | Option exercise · Stock Option 10b5-1 | −417 | 5,000 | D | ||
| Open-market sales · 417 sh · avg $25.65 · $10,696 | |||||||
Loading xslF345X05/wk-form4_1773780674.xml…